BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1374293)

  • 61. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.
    Chen Y; Kuchroo VK; Inobe J; Hafler DA; Weiner HL
    Science; 1994 Aug; 265(5176):1237-40. PubMed ID: 7520605
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein.
    Wucherpfennig KW; Ota K; Endo N; Seidman JG; Rosenzweig A; Weiner HL; Hafler DA
    Science; 1990 May; 248(4958):1016-9. PubMed ID: 1693015
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis.
    Kumar V; Aziz F; Sercarz E; Miller A
    J Exp Med; 1997 May; 185(10):1725-33. PubMed ID: 9151697
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acquired resistance to experimental autoimmune encephalomyelitis is independent of V beta usage.
    Johnson BD; Nardella JP; McConnell TJ; Mannie MD
    Cell Immunol; 1997 Jul; 179(1):55-65. PubMed ID: 9259772
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
    Bebo BF; Vandenbark AA; Offner H
    J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3.
    Gold DP; Offner H; Sun D; Wiley S; Vandenbark AA; Wilson DB
    J Exp Med; 1991 Dec; 174(6):1467-76. PubMed ID: 1836012
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Suppressive activity of long-term myelin basic protein-specific SJL T cell lines.
    Barzaga-Gilbert ME; Skeen MJ; Chou CH; Fritz RB
    J Neuroimmunol; 1989 Aug; 23(3):241-7. PubMed ID: 2473998
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preferential distribution of V beta 8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis.
    Tsuchida M; Matsumoto Y; Hirahara H; Hanawa H; Tomiyama K; Abo T
    Eur J Immunol; 1993 Oct; 23(10):2399-406. PubMed ID: 7691605
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen.
    Soos JM; Hobeika AC; Butfiloski EJ; Schiffenbauer J; Johnson HM
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6082-6. PubMed ID: 7541140
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Localization of an encephalitogenic epitope for the SJL mouse in the N-terminal region of myelin basic protein.
    Fritz RB; Skeen MJ; Chou CH; Zamvil SS
    J Neuroimmunol; 1990 Mar; 26(3):239-43. PubMed ID: 1689745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of the tyrosine phosphatase SRC homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis.
    Deng C; Minguela A; Hussain RZ; Lovett-Racke AE; Radu C; Ward ES; Racke MK
    J Immunol; 2002 May; 168(9):4511-8. PubMed ID: 11970996
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 74. T cell receptor expression and differential proliferative responses by T cells specific to a myasthenogenic peptide.
    Kirshner SL; Waisman A; Zisman E; Ben-Nun A; Mozes E
    Cell Immunol; 1997 Aug; 180(1):20-8. PubMed ID: 9316635
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis.
    Jones RE; Bourdette D; Moes N; Vandenbark A; Zamora A; Offner H
    J Immunol; 2003 Feb; 170(4):1690-8. PubMed ID: 12574332
    [TBL] [Abstract][Full Text] [Related]  

  • 77. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
    Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
    J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Delineation of two encephalitogenic myelin basic protein epitopes for DA rats.
    Smeltz RB; Wolf NA; Swanborg RH
    J Neuroimmunol; 1998 Jul; 87(1-2):43-8. PubMed ID: 9670844
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
    Tan LJ; Kennedy MK; Miller SD
    J Immunol; 1992 May; 148(9):2748-55. PubMed ID: 1374098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.